Developer of an insurance and well-being platform designed to provide insurance plans that inspire life and reward livin
Developer of an insurance and well-being platform designed to provide insurance plans that inspire life and reward living.
Life and Health Insurance📍 London, United KingdomFounded 2016
Current Valuation
$947.22M
as of 2022-Q3
PRIVATE
QL Price
$947.22M
0% vs last round
QuantLogix's current estimate for YuLife, published 2026-09-27 — in line with the last disclosed round of $947.22M (2022-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$947.22M
2022-Q3
weight 0.06
How this price has held up
No round has priced for YuLife since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, YuLife, 2026-09-27 (a8cd3ae20b241031).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is YuLife going public?
No. YuLife is private and has not filed to go public. There is no S-1 on file.
What is YuLife's valuation in 2026?
YuLife is valued at $947.22M as of 2022-Q3, set by its Series C ($116.11M, Jul 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has YuLife filed an S-1?
No public S-1 is on file for YuLife.
How much has YuLife raised?
YuLife has raised $225.89M in total, most recently a Series C of $116.11M in Jul 2022.
Is YuLife publicly traded — can you buy YuLife stock?
No. YuLife is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for YuLife on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
London, United Kingdom
Employees
285
Total Raised
$225.89M
Last Round
Series C — $116.11M (Jul 2022)
IPO Status
private
Fundraising Status
Series C · $116.11M · 4y 2mo ago
privateTotal raised $225.89M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$116.11M
Jul 2022
—
$947.22M
Talent Signal
Hiring trend
▼ Hiring downtrend
-29% vs 2026-08
Open roles
5
via careers page
Product-build share
40%
engineering, research, product, design
Trajectory
tightening
balanced build + GTM — 40% builders vs 60% go-to-market/G&A — scaling both sides.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Dr. John Ronayne, Lead Data ScientistProduct OwnerMental health supportSales Development RepresentativeWork with the best insurance & tech talent
Counted from YuLife's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Employee BenefitsInsuranceLife InsuranceWellness
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q3. Refreshed quarterly.